Physician profile
Jill Study
NPI 1114585726
$23,722.69
in general payments reported to CMS, 2019-2025
32 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,608 · 2022: $2,530 · 2023: $4,520 · 2024: $1,051 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,218 · Travel and Lodging: $4,536 · Consulting Fee: $3,926 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,850 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,217.81 |
| Travel and Lodging | $4,536.33 |
| Consulting Fee | $3,925.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,850.00 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $10,122.79 | 2025 | Senza |
| Saluda Medical Americas, INC. | $2,974.61 | 2023-2025 | Evoke Scs, Evoke |
| Vertos Medical, INC. | $2,118.36 | 2021-2024 | Mild Device Kit |
| Medtronic, INC. | $1,724.09 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Nevro Corp. | $1,722.72 | 2021-2024 | Senza |
| Nalu Medical, INC. | $1,370.83 | 2021-2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $763.50 | 2021-2022 | |
| Abbvie INC. | $533.25 | 2022-2025 | |
| Spr Therapeutics, INC | $319.14 | 2021-2025 | Sprint Pns System |
| Pfizer INC. | $237.83 | 2023-2025 | |
| Curonix LLC | $235.86 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $235.78 | 2021-2025 | Xtampza, Belbuca |
| Biodelivery Sciences International, INC. | $176.11 | 2021 | |
| Mml US, INC. | $175.36 | 2024 | Reactiv8 |
| Si-Bone, INC. | $133.94 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $115.56 | 2021-2022 | |
| Abbott Laboratories | $113.81 | 2025 | Proclaim |
| Tonix Medicines, INC. | $94.25 | 2025 | Tonmya |
| Vertex Pharmaceuticals Incorporated | $86.02 | 2024-2025 | |
| Relievant Medsystems, INC. | $82.62 | 2023 | Intracept |
| Scilex Pharmaceuticals INC. | $76.90 | 2022-2024 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Hikma Pharmaceuticals USA | $38.56 | 2022 | |
| Horizon Therapeutics Plc | $34.78 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $33.74 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.23 | 2022 | |
| Almatica Pharma LLC | $30.43 | 2021 | |
| Alkermes, INC. | $22.94 | 2023 | Vivitrol |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.54 | 2022 | |
| Redhill Biopharma INC. | $19.62 | 2021 | |
| Indivior INC. | $19.41 | 2023 | Sublocade |
| Impel Pharmaceuticals INC. | $13.11 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Study listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.